We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
TNO Extends Licensing Agreement with Genego
News

TNO Extends Licensing Agreement with Genego

TNO Extends Licensing Agreement with Genego
News

TNO Extends Licensing Agreement with Genego

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "TNO Extends Licensing Agreement with Genego"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

GeneGo, Inc. has announced that TNO, The European Nutrigenomics Organisation (NUGO) Consortium and The Netherlands Nutrigenomics Consortium (NGC) have extended their agreement with Genego. Further, the recently established Netherlands Toxicogenomics Centre (NTC) will soon acquire MetaCore and MetaDrug for applications in toxicogenomics.

This provides over 20 universities in Europe with access to MetaCore. GeneGo has a Rodent version of MetaCore with rat and mouse genes, protein complexes and interactions. This is the first species specific database which is not derived from ortholog matching. This level of detail is crucial for nutritionists and toxicologists who deduce human efficacy and toxicity based on animal models data.

“We have established a close relationship with TNO over the years”, said Julie Bryant, GeneGo’s VP of Business development. “The projects we collaborate on include a study on cholesterol diet and drug effects on atherosclerosis and nutrigenomics. TNO is also using GeneGo products as part of their tox service offerings. We look forward to further collaborations and more publications.”

Advertisement